Jul 13, 2026 04:06PM
Jul 13, 2026 04:05PM
Jul 7, 2026 08:02AM
Jul 7, 2026 08:00AM
Jun 19, 2026 04:02PM
May 28, 2026 08:00AM
May 12, 2026 05:00PM Eupraxia Pharmaceuticals Reports First Quarter 2026 Financial Results
May 6, 2026 07:00AM
May 6, 2026 07:00AM
May 5, 2026 07:00AM
May 5, 2026 07:00AM
May 1, 2026 05:05PM
May 1, 2026 05:05PM
Apr 22, 2026 07:00AM Eupraxia Pharmaceuticals to Present at Digestive Disease Week Annual Meeting
Apr 21, 2026 07:00AM
Apr 21, 2026 07:00AM
Apr 13, 2026 08:00AM
Mar 17, 2026 07:00AM
Mar 17, 2026 07:00AM
Mar 12, 2026 09:03PM
Jan 8, 2026 07:34AM Eupraxia reports positive tissue health data from EoE trial
Jan 8, 2026 07:34AM
Nov 13, 2025 05:00PM
Nov 13, 2025 05:00PM
Nov 4, 2025 04:39PM
Sep 29, 2025 05:00PM
Sep 29, 2025 05:00PM
Sep 2, 2025 08:02AM Eupraxia reports sustained 12-month results from eosinophilic esophagitis trial
Sep 2, 2025 08:00AM
Sep 2, 2025 08:00AM
Aug 12, 2025 04:25PM
Jul 22, 2025 05:17PM
Jul 8, 2025 07:00AM
Jul 8, 2025 07:00AM
Jun 2, 2025 06:30PM Eupraxia Pharmaceuticals Announces Voting Results from Annual General and Special Meeting of Shareholders
May 7, 2025 02:00PM
May 6, 2025 06:00PM
May 5, 2025 07:00AM
Apr 24, 2025 05:00PM
Mar 20, 2025 05:32PM
Feb 25, 2025 07:01AM
Feb 25, 2025 07:00AM Eupraxia Pharmaceuticals Announces Positive Data from RESOLVE Phase 1b/2a Trial of EP-104GI for Treatment of Eosinophilic Esophagitis
Feb 18, 2025 07:00AM
Feb 18, 2025 07:00AM
Nov 20, 2024 07:00AM
Nov 14, 2024 05:00PM
Nov 13, 2024 05:00PM
Nov 12, 2024 05:56PM
Oct 31, 2024 07:36PM Eupraxia Pharmaceuticals Announces that it has Closed a Non-Brokered Private Placement of C$44.5 Million
Oct 28, 2024 07:00AM

325,894 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All